AU2003236632B2 - Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof - Google Patents

Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof Download PDF

Info

Publication number
AU2003236632B2
AU2003236632B2 AU2003236632A AU2003236632A AU2003236632B2 AU 2003236632 B2 AU2003236632 B2 AU 2003236632B2 AU 2003236632 A AU2003236632 A AU 2003236632A AU 2003236632 A AU2003236632 A AU 2003236632A AU 2003236632 B2 AU2003236632 B2 AU 2003236632B2
Authority
AU
Australia
Prior art keywords
preparation according
cellulose
active substance
preparation
film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003236632A
Other languages
English (en)
Other versions
AU2003236632A1 (en
Inventor
Markus Krumme
Walter Muller
Christian Von Falkenhausen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU2003236632A1 publication Critical patent/AU2003236632A1/en
Application granted granted Critical
Publication of AU2003236632B2 publication Critical patent/AU2003236632B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2003236632A 2002-06-04 2003-05-08 Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof Ceased AU2003236632B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10224612A DE10224612A1 (de) 2002-06-04 2002-06-04 Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
DE10224612.2 2002-06-04
PCT/EP2003/004816 WO2003101421A1 (de) 2002-06-04 2003-05-08 Wirkstoffhaltige filmförmige zubereitungen mit verbesserter chemischer stabilität, und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
AU2003236632A1 AU2003236632A1 (en) 2003-12-19
AU2003236632B2 true AU2003236632B2 (en) 2008-07-31

Family

ID=29594232

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003236632A Ceased AU2003236632B2 (en) 2002-06-04 2003-05-08 Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof

Country Status (15)

Country Link
US (1) US20050226823A1 (enExample)
EP (1) EP1509201B1 (enExample)
JP (1) JP2005528427A (enExample)
KR (1) KR20050010024A (enExample)
CN (1) CN1658833A (enExample)
AR (1) AR039955A1 (enExample)
AT (1) ATE426400T1 (enExample)
AU (1) AU2003236632B2 (enExample)
BR (1) BR0311663A (enExample)
CA (1) CA2487590C (enExample)
DE (2) DE10224612A1 (enExample)
ES (1) ES2324909T3 (enExample)
RU (1) RU2311900C2 (enExample)
TW (1) TWI344373B (enExample)
WO (1) WO2003101421A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2351315C2 (ru) * 2003-07-24 2009-04-10 Смитклайн Бичам Корпорейшн Пленки, растворяющиеся в полости рта
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
AR051397A1 (es) * 2004-10-21 2007-01-10 Novartis Ag Composicion farmaceutica
DE102005005974A1 (de) * 2005-02-09 2006-08-10 Basf Ag Verfahren zur Stabilisierung von Polyvinylpyrrolidonen
WO2006135491A2 (en) * 2005-06-08 2006-12-21 Basf Aktiengesellschaft Medicament carrier composition and method of forming a film therefrom
WO2007034287A2 (en) * 2005-09-19 2007-03-29 University Of The Witwatersrand, Johannesburg Oramucosal pharmaceutical dosage form
KR100742432B1 (ko) * 2005-12-27 2007-07-24 한미약품 주식회사 암로디핀 캠실레이트 및 심바스타틴을 포함하는 복합제제,및 이의 제조방법
FR2902655B1 (fr) * 2006-06-23 2008-11-28 Oreal Compositon topique a effet froid
RU2418574C2 (ru) * 2007-02-08 2011-05-20 Медтроник Ксомед Инк. Сольватирующая система и герметик для медицинского применения
JP5138765B2 (ja) * 2008-03-18 2013-02-06 日本たばこ産業株式会社 シガレット主流煙成分吸着剤およびシガレット用フィルタ
EA201170287A1 (ru) * 2008-08-01 2011-10-31 Дзе Медсинз Компани Фармацевтические композиции и способы их стабилизации
ES2699077T3 (es) 2009-06-12 2019-02-07 Sunovion Pharmaceuticals Inc Apomorfina sublingual
EA031156B1 (ru) 2010-12-16 2018-11-30 Суновион Фармасьютикалз Инк. Сублингвальные пленки
JP5725940B2 (ja) * 2011-04-01 2015-05-27 日東電工株式会社 ニコチン含有貼付製剤
CN103788552B (zh) * 2012-10-26 2016-12-21 厦门加岩高分子材料有限公司 聚乙烯醇共混物
SG11201610636VA (en) * 2014-06-20 2017-01-27 Ctc Bio Inc Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
WO2016172095A1 (en) 2015-04-21 2016-10-27 Cynapsus Therapeutics, Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
WO2017081725A1 (ja) * 2015-11-09 2017-05-18 花王株式会社 口腔用組成物
US11648212B2 (en) * 2016-02-03 2023-05-16 Intelgenx Corp. Loxapine film oral dosage form
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten
WO2019171843A1 (ja) * 2018-03-05 2019-09-12 パナソニックＩｐマネジメント株式会社 化粧料または医療材料
IT201800011125A1 (it) 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide comprendenti matrici monolitiche complesse per la somministrazione cronotropica di medicamenti nel tratto gastroenterico
CN110339118B (zh) * 2019-08-19 2022-08-16 广州明辉化妆品有限公司 具有美白保湿功效的美白霜
SE544672C2 (en) 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
IT202000011050A1 (it) 2020-05-14 2021-11-14 Mogon Pharmaceuticals Sagl Composizioni orali solide comprendenti matrici monolitiche composite per la somministrazione cronotropica nel tratto gastroenterico di ingredienti attivi
IT202000011053A1 (it) 2020-05-14 2021-11-14 Int Health Science S R L Composizioni orali solide comprendenti matrici monolitiche composite per la somministrazione cronotropica nel tratto gastroenterico di alimenti, integratori alimentari, nutraceutici, dispositivi medici

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380367A1 (en) * 1989-01-27 1990-08-01 Stafford-Miller Ltd. Compositions and method for the treatment of disease
EP0539215A1 (en) * 1991-10-23 1993-04-28 Stafford-Miller Ltd. Penetration enhancement of topically applied formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2019275B3 (es) * 1985-10-09 1991-06-16 Desitin Arzneimittel Gmbh Metodo para la produccion de una forma de administracion y de dosificacion para farmacos reactivos u otros principios activos.
IL97930A (en) * 1991-04-23 1996-06-18 Perio Prod Ltd Preparations for whitening two controlled release products that contain a super-oxygen compound
AU4327193A (en) * 1992-07-08 1994-01-31 Dianorm-Gerate G. Maierhofer Liposomes, method of preparing them and their use in the preparation of drugs
DE69724424T2 (de) * 1996-05-13 2004-06-24 Novartis Consumer Health S.A. Mundfreisetzungssystem
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
RU2155071C1 (ru) * 1999-08-10 2000-08-27 Мизина Прасковья Георгиевна Способ получения лекарственной фитопленки
JP5753645B2 (ja) * 1999-11-29 2015-07-22 エルテーエス ローマン テラピー−ジステーメ アーゲー 安定性が改善された経皮治療システムおよびそれらの製法
DE10018834A1 (de) * 2000-04-15 2001-10-25 Lohmann Therapie Syst Lts Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
RU2195545C1 (ru) * 2001-08-14 2002-12-27 Хаминов Николай Иванович Способ изоляции промытых зон в добывающей и нагнетательной скважинах

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380367A1 (en) * 1989-01-27 1990-08-01 Stafford-Miller Ltd. Compositions and method for the treatment of disease
EP0539215A1 (en) * 1991-10-23 1993-04-28 Stafford-Miller Ltd. Penetration enhancement of topically applied formulations

Also Published As

Publication number Publication date
TW200307566A (en) 2003-12-16
ATE426400T1 (de) 2009-04-15
US20050226823A1 (en) 2005-10-13
AU2003236632A1 (en) 2003-12-19
WO2003101421A1 (de) 2003-12-11
AR039955A1 (es) 2005-03-09
TWI344373B (en) 2011-07-01
DE10224612A1 (de) 2003-12-24
BR0311663A (pt) 2005-06-28
CA2487590A1 (en) 2003-12-11
ES2324909T3 (es) 2009-08-19
EP1509201A1 (de) 2005-03-02
EP1509201B1 (de) 2009-03-25
RU2311900C2 (ru) 2007-12-10
JP2005528427A (ja) 2005-09-22
CA2487590C (en) 2011-01-11
KR20050010024A (ko) 2005-01-26
RU2004136576A (ru) 2005-08-27
DE50311338D1 (de) 2009-05-07
CN1658833A (zh) 2005-08-24
WO2003101421A8 (de) 2005-04-21

Similar Documents

Publication Publication Date Title
AU2003236632B2 (en) Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof
AU2003240824B2 (en) Transmucosal delivery of cannabinoids
TWI548426B (zh) 己烯雌酚之劑型及治療方法
CA3125807C (en) Oral thin film comprising cannabinoids
US20100041703A1 (en) Rapid disintegration monolayer film for the oral administration of active substances
WO2020260726A1 (en) Transmucosal therapeutic system containing agomelatine
KR20150048409A (ko) 고체분산체 형태의 타달라필을 함유하는 구강 붕해 필름 및 이의 제조방법
CZ283645B6 (cs) Tablety s obsahem ranitidinu a způsob výroby povlaku
JP2006316009A (ja) 口腔内貼付剤及びその製造方法
RU2296568C1 (ru) Инъекционная лекарственная форма для лечения и профилактики кровепаразитарных и инвазионных заболеваний
EP2213278A1 (de) Pharmazeutische Zubereitung mit verbesserter Stabilität des Wirkstoffs
JP2538491B2 (ja) 味をマスキングされた薬物及びそれらの製法
JP2006182669A (ja) 口腔内貼付剤
JP2005289939A (ja) 口腔内貼付剤
WO2025036496A1 (en) Oral thin film comprising lurasidone
EP4551190A1 (en) Oral thin films comprising adrenaline
KR20240161570A (ko) 장용성 코팅용 조성물 및 이를 이용한 정제의 제조 방법
KR20050042846A (ko) 안정화된 과산화물을 함유한 치아미백용 건조필름의조성물 및 그 제조방법
MX2008007383A (en) Complex formulation comprising amlodipine camsylate and simvastatin and method for preparation thereof
EP3423045A1 (en) Pharmaceutical compositions for on demand anticoagulant therapy

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired